Skip to content
September 16, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Treatment Innovations
  • The Governance Gap: Navigating the Rise of Agentic AI in Modern Healthcare
  • Treatment Innovations

The Governance Gap: Navigating the Rise of Agentic AI in Modern Healthcare

Ali Ikhwan September 16, 2026 7 minutes read
the-governance-gap-navigating-the-rise-of-agentic-ai-in-modern-healthcare

As the healthcare industry stands on the precipice of a digital transformation, the integration of Artificial Intelligence (AI) has moved from a theoretical aspiration to an operational reality. However, a new study by digital identity and security specialist Imprivata reveals a stark reality: while traditional AI is being rapidly adopted, the transition to "agentic" AI—autonomous systems capable of executing complex tasks without constant human intervention—is being hamstrung by a pervasive, industry-wide crisis of governance and security oversight.

The State of Play: From Passive AI to Autonomous Agents

For years, healthcare systems have experimented with passive AI tools designed to assist in data analysis, imaging, and administrative sorting. These tools, which function primarily as decision-support systems, have paved the way for broader adoption. According to Imprivata’s latest survey, which polled management across a diverse spectrum of healthcare entities—including single-specialty hospitals, large-scale health systems, and academic medical centers—the deployment of AI is now common, with 83% of respondents confirming they have already integrated some form of AI into their workflows.

Yet, a significant "capability gap" persists. Only 28% of those surveyed have successfully moved to the next level: agentic AI. Unlike their predecessors, agentic models do not merely suggest paths; they possess the autonomy to interact with systems, retrieve patient data, and perform workflows on behalf of clinicians.

The industry is clearly preparing for a shift. The survey data indicates that 44% of healthcare organizations are currently running proof-of-concept (PoC) projects involving agentic AI, with an additional 21% aiming to deploy such technology within the next twelve months. Over three-quarters of participants believe that agentic AI will ultimately deliver a transformative impact on both clinical and operational outcomes.

Chronology of Adoption and the "Shadow AI" Phenomenon

The current landscape of AI deployment in healthcare is not uniform, nor is it entirely centralized. The chronology of this transition reveals a troubling trend: the emergence of "Shadow AI."

In the early stages of adoption, IT departments were the gatekeepers of innovation. However, as AI tools became more accessible via cloud-based APIs and third-party software, individual departments and clinicians began bypassing standard procurement channels. The Imprivata survey highlights a startling statistic: 72% of respondents report that AI tools or agents are being deployed without formal IT approval "at least occasionally."

This fragmented approach to implementation is creating a decentralized digital ecosystem where IT and cybersecurity teams are often unaware of the breadth of AI agents operating within their network perimeters. This lack of visibility is not just a policy failure; it is a fundamental security risk. When autonomous agents operate outside the purview of formal governance, they lack the necessary guardrails to prevent data breaches, unauthorized access to Electronic Health Records (EHRs), and regulatory non-compliance.

Supporting Data: The Barriers to Scaled Success

The reluctance to fully embrace agentic AI is not rooted in a lack of vision, but in a fear of systemic failure. The data identifies clear bottlenecks:

  • Security and Governance: Nearly 80% of respondents identified security, model identity, or governance frameworks as the primary barriers to scaling.
  • Access Permissions: 57% of leaders view excessive access permissions as a top-tier threat. In an autonomous environment, if an agent has "admin-level" access, a single malfunction or malicious prompt injection could compromise the entire patient database.
  • Compliance Violations: Approximately 50% of participants expressed deep concerns regarding regulatory and compliance violations, fearing that autonomous decision-making could run afoul of HIPAA or international data privacy laws.

The market outlook for this technology remains bullish, however. According to recent findings from GlobalData, the combined AI market across healthcare, pharmaceuticals, and medical devices was valued at $11.9 billion in 2024. Projections estimate this will surge to $57.4 billion by 2029, reflecting a staggering compound annual growth rate (CAGR) of 37%. The financial incentive to adopt is high, but the cost of mismanagement could be catastrophic.

Agentic AI trust gap slowing healthcare provider adoption, survey reveals 

Official Perspectives: The Framework for Effective Governance

The consensus among industry experts, as echoed by Imprivata, is that the "Wild West" era of AI implementation must end. To bridge the gap between innovation and safety, healthcare organizations must pivot toward a rigorous, multi-disciplinary accountability model.

Defining Agent Identity

The first pillar of robust governance is the establishment of "model identity." Just as human employees have role-based access controls, AI agents must be assigned distinct identities. This ensures that an AI performing medication reconciliation does not have the same access rights as an AI managing facility maintenance or supply chain logistics.

Continuous Monitoring and "Step-Up" Authentication

Active monitoring is the second pillar. Imprivata emphasizes that monitoring should be risk-adjusted. Not all AI agents are equal; a model providing low-stakes administrative suggestions requires less oversight than one directly influencing patient care. For high-risk activities—such as those involving EHR access or clinical decision support—the system should trigger "step-up" authentication, requiring human intervention or multi-factor approval before an agent can finalize a task.

The Multi-Disciplinary Mandate

Effective governance cannot reside solely within the IT department. Imprivata advocates for a "cross-functional governance committee" that includes:

  • Executive Leadership: To ensure strategic alignment and budget for security.
  • Clinical Leadership: To validate the clinical safety and explainability of AI recommendations.
  • Cybersecurity and IT: To maintain the digital infrastructure and manage identity access.
  • Legal and Compliance: To ensure that all autonomous actions are auditable and satisfy regulatory mandates.

Implications: The Path Toward Resilient Healthcare

The implications of failing to address these governance gaps are significant. If healthcare providers continue to deploy agentic AI in a fragmented, unmonitored manner, they risk not only data breaches but also a degradation of the clinician-patient relationship. If a clinician cannot explain why an autonomous agent made a specific recommendation, the "black box" nature of the model becomes a liability during medical malpractice proceedings.

Conversely, those organizations that successfully implement "airtight" governance will realize immense benefits. By automating high-volume, low-complexity administrative tasks, providers can alleviate the crushing burden of burnout that currently plagues the medical profession. When agents function under strict, transparent, and auditable guardrails, clinicians are empowered to focus on the high-touch, empathetic care that only humans can provide.

The Future of Accountability

The ultimate goal is an environment where every AI action is logged, monitored, and—critically—explainable. During an audit, a hospital must be able to trace a specific action back to the agent, the model version, and the data source used to arrive at a conclusion.

As we look toward 2029, the distinction between successful health systems and those that struggle will likely be their ability to govern autonomy. As the $57.4 billion market matures, the competitive advantage will shift away from who has the most "advanced" AI and toward who has the most "trustworthy" AI.

In conclusion, the transition to agentic AI is not merely a technical challenge; it is a cultural and organizational shift. By moving away from shadow deployments and toward a centralized, multi-disciplinary accountability framework, healthcare providers can harness the transformative potential of autonomous agents, ensuring that the technology serves the patient, protects the data, and strengthens the integrity of the clinical workflow. The path to a more efficient healthcare system is paved with AI, but it must be built on a foundation of unshakeable governance.

About the Author

Ali Ikhwan

Author

View All Posts

Post navigation

Previous: Strengthening Global Resilience: France and the World Health Organization Forge New Strategic Partnership
Next: The Price of Uncertainty: Why Breast Reconstruction Costs Remain Hidden Despite Federal Transparency Mandates

Related Stories

bridging-the-gap-gilead-and-nucleai-harness-ai-to-solve-the-adc-resistance-paradox
  • Treatment Innovations

Bridging the Gap: Gilead and Nucleai Harness AI to Solve the ADC Resistance Paradox

Muslim September 16, 2026
the-race-for-innovation-fda-launches-operation-trialblazer-to-stem-the-tide-of-overseas-clinical-trials
  • Treatment Innovations

The Race for Innovation: FDA Launches “Operation Trialblazer” to Stem the Tide of Overseas Clinical Trials

Nana September 16, 2026
a-potential-breakthrough-psilocybin-shows-promise-in-preventing-chemotherapy-induced-nerve-damage
  • Treatment Innovations

A Potential Breakthrough: Psilocybin Shows Promise in Preventing Chemotherapy-Induced Nerve Damage

Azzam Bilal Chamdy September 16, 2026

Recent Posts

  • Navigating the Post-Pandemic Data Landscape: A Comprehensive Review of Global COVID-19 Tracking and Policy Evolution
  • METAvivor Announces Strategic Transition to Bloomerang for Peer-to-Peer Fundraising
  • The Heart of the Wiregrass: How Dothan, Alabama, Cultivated a Global Legacy
  • Bridging the Gap: Gilead and Nucleai Harness AI to Solve the ADC Resistance Paradox
  • The Price of Uncertainty: Why Breast Reconstruction Costs Remain Hidden Despite Federal Transparency Mandates

Recent Comments

No comments to show.

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

navigating-the-post-pandemic-data-landscape-a-comprehensive-review-of-global-covid-19-tracking-and-policy-evolution
  • Breast Cancer Legislation and Policy

Navigating the Post-Pandemic Data Landscape: A Comprehensive Review of Global COVID-19 Tracking and Policy Evolution

Siti Muinah September 16, 2026
metavivor-announces-strategic-transition-to-bloomerang-for-peer-to-peer-fundraising-1
  • Metastatic Breast Cancer Research

METAvivor Announces Strategic Transition to Bloomerang for Peer-to-Peer Fundraising

Lina Irawan September 16, 2026
the-heart-of-the-wiregrass-how-dothan-alabama-cultivated-a-global-legacy
  • Genomics and Precision Medicine

The Heart of the Wiregrass: How Dothan, Alabama, Cultivated a Global Legacy

Neng Nana September 16, 2026
bridging-the-gap-gilead-and-nucleai-harness-ai-to-solve-the-adc-resistance-paradox
  • Treatment Innovations

Bridging the Gap: Gilead and Nucleai Harness AI to Solve the ADC Resistance Paradox

Muslim September 16, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.